| scholarly article | Q13442814 |
| P50 | author | Stéphane Mélik Parsadaniantz | Q56512551 |
| Hong Liang | Q37384912 | ||
| P2093 | author name string | Christophe Baudouin | |
| Françoise Brignole-Baudouin | |||
| Karima Kessal | |||
| Mylene Docquier | |||
| Philippe Daull | |||
| Jean-Sébastien Garrigue | |||
| Ghislaine Rabut | |||
| P2860 | cites work | Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca | Q72993423 |
| Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation | Q73434690 | ||
| Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes | Q81357274 | ||
| Regulation of immunity and oncogenesis by the IRF transcription factor family | Q24293755 | ||
| Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes | Q24312187 | ||
| Induction of the human gene for p44, a hepatitis-C-associated microtubular aggregate protein, by interferon-alpha/beta | Q24322091 | ||
| TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex | Q24329065 | ||
| Associations between signs and symptoms of dry eye disease: a systematic review | Q26781979 | ||
| Dry eye: an inflammatory ocular disease | Q26852044 | ||
| Interferon-inducible antiviral effectors | Q27486790 | ||
| Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide | Q27731272 | ||
| Endoplasmic reticulum-associated ubiquitin-conjugating enzyme Ube2j1 is a novel substrate of MK2 (MAPKAP kinase-2) involved in MK2-mediated TNFα production | Q28118356 | ||
| CD40-CD40 ligand | Q28143324 | ||
| HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells | Q28204312 | ||
| Genetic control of MHC class II expression | Q28216149 | ||
| The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling | Q28247905 | ||
| Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine | Q28287650 | ||
| Interferon-induced Mx proteins in antiviral host defense | Q28306408 | ||
| Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII | Q28576309 | ||
| Cloning and characterization of ALX, an adaptor downstream of CD28 | Q28589773 | ||
| MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis | Q28593865 | ||
| Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death | Q28609905 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| Direct multiplexed measurement of gene expression with color-coded probe pairs | Q29614417 | ||
| Leukocyte migration and graft-versus-host disease | Q30479618 | ||
| Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. | Q31775977 | ||
| Fas- and interferon gamma-induced apoptosis in Chang conjunctival cells: further investigations. | Q33180870 | ||
| The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research | Q33756582 | ||
| Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease | Q33869200 | ||
| Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. | Q54664601 | ||
| CCR4 and CCR5 expression in conjunctival specimens as differential markers of TH1/ TH2 in ocular surface disorders | Q57693376 | ||
| Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes | Q57693415 | ||
| Conjunctival Epithelium Expression of HLA-DR in Dry Eye Patients | Q58205031 | ||
| Expression of Toll-like Receptors in Healthy and Allergic Conjunctiva | Q61684982 | ||
| TNF and MAP kinase signalling pathways | Q33905516 | ||
| Lineage commitment in the immune system: the T helper lymphocyte grows up. | Q33970744 | ||
| Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. | Q34028408 | ||
| Salivary chemokine levels in patients with primary Sjogren's syndrome. | Q34056242 | ||
| p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. | Q34483284 | ||
| Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells | Q34629176 | ||
| Dry eye as a mucosal autoimmune disease | Q34647761 | ||
| High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses | Q35679560 | ||
| Peripheral blood gene expression profiling in Sjögren's syndrome | Q35740973 | ||
| Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies. | Q35755171 | ||
| Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro | Q35767631 | ||
| Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease | Q35907009 | ||
| Regulation of MHC class II gene expression by the class II transactivator | Q36274925 | ||
| Evaluation of the transforming growth factor-beta activity in normal and dry eye human tears by CCL-185 cell bioassay | Q36637782 | ||
| Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome | Q36676823 | ||
| Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection | Q36781320 | ||
| The role of complement in inflammation and phagocytosis | Q36845189 | ||
| On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5'oligoadenylate synthetases and the protein kinase PKR. | Q36903412 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Recognition of viruses by innate immunity. | Q36990625 | ||
| The Mx GTPase family of interferon-induced antiviral proteins | Q37026048 | ||
| Interferon regulatory factor-1 in flagellin-induced reprogramming: potential protective role of CXCL10 in cornea innate defense against Pseudomonas aeruginosa infection | Q37320379 | ||
| Expression of toll-like receptors in human limbal and conjunctival epithelial cells. | Q37402189 | ||
| Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis | Q37636027 | ||
| Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway | Q37685316 | ||
| Toll-like receptors in ocular surface disease | Q37719810 | ||
| Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting | Q38151227 | ||
| Toll-like receptor signaling pathways | Q38259564 | ||
| Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways | Q38332047 | ||
| Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L. | Q38336230 | ||
| Evaluating Robustness and Sensitivity of the NanoString Technologies nCounter Platform to Enable Multiplexed Gene Expression Analysis of Clinical Samples | Q38526148 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting | Q38733230 | ||
| Gene expression markers of Tumor Infiltrating Leukocytes | Q38752940 | ||
| NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics. | Q38787248 | ||
| Correlation Between the Inflammatory Marker HLA-DR and Signs and Symptoms in Moderate to Severe Dry Eye Disease | Q38816983 | ||
| IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency | Q38899135 | ||
| Rho GTPase Cdc42 is essential for human T-cell development | Q39434275 | ||
| Activation and control of the complement system | Q39761363 | ||
| Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. | Q40085683 | ||
| Variation in the expression of inflammatory markers and neuroreceptors in human conjunctival epithelial cells | Q40184393 | ||
| Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells | Q40327809 | ||
| IFN-γ-Induced MHC Class II Expression: Transactivation of Class II Transactivator Promoter IV by IFN Regulatory Factor-1 is Regulated by Protein Kinase C-α | Q40628561 | ||
| Subcellular localization of Toll-like receptor 3 in human dendritic cells | Q40636721 | ||
| Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells. | Q40844750 | ||
| High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization | Q40937646 | ||
| Regulation of human leukocyte antigen expression in human conjunctival epithelium | Q40980938 | ||
| Transforming growth factor-beta: a general review | Q41255594 | ||
| Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus. | Q41688983 | ||
| HMGN1 and 2 remodel core and linker histone tail domains within chromatin | Q41859438 | ||
| CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization | Q42060069 | ||
| Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease | Q42496546 | ||
| Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles | Q42825650 | ||
| Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses | Q43709819 | ||
| Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease | Q43723395 | ||
| Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin A. | Q44339254 | ||
| Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface | Q45158772 | ||
| Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca | Q45190856 | ||
| Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease | Q45229126 | ||
| Inflammation in dry eye. | Q46372528 | ||
| Adaptation of impression cytology to enable conjunctival surface cell transcriptome analysis | Q46834579 | ||
| Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome | Q47807754 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 2271 | |
| P577 | publication date | 2018-10-15 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Conjunctival Inflammatory Gene Expression Profiling in Dry Eye Disease: Correlations With HLA-DRA and HLA-DRB1 | |
| P478 | volume | 9 |
| Q90403120 | Update on the role of impression cytology in ocular surface disease | cites work | P2860 |
Search more.